Following the Scent of Discovery: Digital Strategies Changing the Face of Parkinson’s Research

December 8, 2025

Across a global network of medical centers, from Mass General to University College London, The Michael J. Fox Foundation leads a research initiative reshaping how we study, detect, and hope to stop Parkinson’s disease. At the heart of it all is a simple scratch-and-sniff smell test with extraordinary potential.

// By Susan Dubuque //

Susan Dubuque, a strategist and writer specializing in health care and behavior change, was a cofounder and principal of Two Tango (formerly NDP Agency).This September marked a milestone in medical research: 15 years since the first volunteer enrolled in the Parkinson’s Progression Markers Initiative (PPMI), the flagship study of The Michael J. Fox Foundation for Parkinson’s Research (MJFF).

Logo - MJFFFrom the start, the vision was bold: Find biological clues that reveal how Parkinson’s develops and progresses. Today, that goal has evolved into one of the world’s most comprehensive open-science data resources on neurodegenerative disease, shaping hundreds of scientific papers and dozens of clinical trials worldwide.

For health care marketers, the story behind PPMI is more than a scientific achievement. It’s a powerful reminder that connection, clarity, and persistence can build a movement.

Keep reading to see how a thoughtful marketing strategy — evolving from early direct mail to advanced digital tactics — helped build the study that’s changing what we know about Parkinson’s.


This content is only available to members.

Please log in.

Not a member yet?

Start a free 7-day trial membership to get instant access.

Log in below to access this content: